Scientific Research and Essays Vol. 2 (9), 370-371, September 2007          
ISSN 1992-2248 © 2007 Academic Journals

Review

Genotyping and NNRTI mutations: where do we go from here as HIV populations get older? A perspective

Eugene Jacquescoley

Projects in Motion USA CCR 914-564-1666; NYU School of Medicine 212-263-7300. E-mail: dr.jacquescoley@jacquescoleypimusaccr.org; eugene.jacquescoley@med.nyu.edu.

Accepted 13 June, 2007

As genotyping procedures have increasingly become more sensitive and complex, HIV scientists and physicians are finding new clinical approaches to treat compromised patient populations on non-nucleoside transcriptase inhibitor (NNRTI) classes of drugs. Further, as age demographics play a vital role in older populations affected with HIV, understanding phenotype/resistance panels for regimen changes is paramount.

Key words: HIV/AIDS, gerontology and geriatrics, micro biology.